Zydus Pharmaceuticals (USA) Inc — FDA Class II (D-0545-2026)

Zydus Pharmaceuticals (USA) Inc is recalling 10,992 bottles of a human prescription drug due to CGMP deviations related to N-Nitros contamination. This recall is classified as a Class II recall. The affected products are distributed in the United States.

• •Zydus Pharmaceuticals is recalling 10,992 bottles of a human prescription drug.
• •The recall is due to contamination with N-Nitros.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the affected products.
• •Recalls like this can lead to increased regulatory scrutiny.

Consumers with the recalled product should stop using it immediately due to potential health risks from contamination. The recall affects 10,992 bottles.